Privi margin widens 5.72 points, but shares fall 11.25% in five sessions
Standalone revenue grew 13.71% YoY as expenses rose 5.38%; management said the company invested Rs 320 cr in capex during FY26.
Filed 11 May 2026, 14:03 IST · Privi Speciality Chemicals Ltd (PRIVISCL)
Key takeaways
- Standalone operating margin expanded 5.72 percentage points YoY as revenue grew 13.71% while expenses rose 5.38%.
- Net profit rose 55.35% YoY despite a 79.82% fall in other income, with lower interest costs supporting the improvement.
- The stock fell 11.25% over five sessions, well beyond its 3.04% median absolute move after the last eight results.
Price around the results
Operating leverage lifted the Q4FY26 margin
Privi's standalone revenue grew 13.71% YoY, while expenses increased only 5.38%, lifting operating margin by 5.72 percentage points. Sequentially, revenue rose 15.34% and expenses 14.54%, helping margin expand another 0.51 percentage points. At 27.63%, the company's operating margin was 8.86 percentage points above the 18.77% median for the 51 Commodities peers that had reported the quarter.
Profit growth was not driven by other income
Net profit increased 55.35% YoY, supported by 43.4% growth in operating profit and a 32.1% decline in interest costs. Other income fell 79.82% YoY and accounted for only 2.07% of pre-tax profit, so it was not a material profit-quality support. The tax rate rose 0.41 percentage points YoY, meaning the earnings increase was not flattered by a lower tax rate.
Margin recovered after the Q2FY26 peak
The standalone operating margin has improved from 21.91% in Q4FY25 to 27.63% in Q4FY26, despite easing from the 28.09% recorded in Q2FY26. The sequential recovery from 27.12% in Q3FY26 marks a second consecutive quarter of revenue growth after the Q3 decline.
Management points to capacity and product expansion
Management said it invested Rs 320 cr in capex during the year and undertook debottlenecking to support growth and improve capacity utilisation. The presentation lists Maltol, Ethyl Maltol, renewable Cyclopentanone and more than 10 other high-end specialty products in the pipeline. Management said it remains focused on its Rs 5,000 cr revenue and Rs 1,000 cr-plus EBITDA vision for FY29-30, and expects EBITDA margins to remain above 20%.
The market reaction was unusually weak for this stock
The stock fell 0.43% on the results date and 8.29% by the next session, extending the decline to 11.25% after five sessions. That compares with a 3.04% median absolute move across the last eight result reactions, of which seven were down. The five-session fall was therefore materially larger than the stock's usual post-results move.
Q4FY26 at a glance
Standalone figures as filed with NSE — cross-checked against an independent source.
| Line item | Q4FY26 | Q3FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹660 cr | ₹573 cr | +15.34% | +13.71% |
| Other income | ₹3 cr | ₹6 cr | -54.31% | -79.82% |
| Expenses | ₹478 cr | ₹417 cr | +14.54% | +5.38% |
| Operating profit | ₹182 cr | ₹155 cr | +17.50% | +43.40% |
| Operating margin (%) | 27.63% | 27.12% | — | — |
| Interest | ₹15 cr | ₹15 cr | -1.23% | -32.10% |
| Depreciation | ₹33 cr | ₹32 cr | +2.52% | +3.71% |
| Profit before tax | ₹138 cr | ₹115 cr | +20.18% | +56.20% |
| Tax | ₹35 cr | ₹29 cr | +21.10% | +58.82% |
| Net profit | ₹103 cr | ₹86 cr | +19.87% | +55.35% |
| EPS (₹) | ₹26.30 | ₹21.94 | +19.87% | +55.35% |
Operating margin of 27.63% compares with a Commodities sector median of 18.77% across 51 peers that have reported Q4FY26.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | -0.43% | +1.06% |
| Next session | -8.29% | — |
| 5 sessions | -11.25% | -9.07% |
| 15 sessions | -5.83% | — |
| 30 sessions | +2.63% | — |
Volume on the results session was 4.17× its 20-day average.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
Guidance & outlook
- Privi is on track to achieve Rs 5,000 crore revenue and Rs 1,000 crore-plus EBITDA by FY29-30.
- The company expects EBITDA margins to remain above 20%.
- Management is focused on delivering its 5k:1k vision over the medium term.
Expansion
- The company undertook debottlenecking initiatives to support future growth and improve capacity utilization.
- Privi invested Rs 320 crore in capital expenditure during the year.
New products
- The company lists Maltol, Ethyl Maltol and renewable Cyclopentanone among its new projects and products.
- More than 10 other high-end specialty products are included in the new product pipeline.
Problems & risks
- The company says it has strengthened its ability to navigate external uncertainties.
What to watch
- Whether standalone operating margin holds above 27.63% after rising 0.51 percentage points QoQ.
- Whether expenses continue to grow more slowly than revenue, as in the quarter's 5.38% YoY versus 13.71%.
- Whether other income remains a small contributor after accounting for 2.07% of pre-tax profit.